Marshall, Gerstein & Borun Named Patent Strategy and Management Team of the Year by LMG Life Sciences

Advertisement - Oliver

Marshall Gerstein & Borun LLP an intellectual property law firm was recognized as Patent Strategy and Management: Team of the Year by LMG Life Sciences during the LMG Life Sciences Awards ceremony held on September 25 2013 at the Essex House in New York City.

The Firm was also shortlisted for Patent Prosecution: Firm of the Year partner Li-Hsien (Lily) Rin-Laures M.D. was a finalist for Patent Prosecution: Attorney of the Year (Pharmaceuticals) and partner David A. Gass was a finalist for Patent Prosecution: Attorney of the Year (Medical Devices).

LMG Life Sciences is the publisher of an annual guide aimed at providing attorneys and law firms with information on the legal market and the U.S. life sciences industry. In the 2013 LMG Life Sciencesguide Marshall Gerstein & Borun is highly recommended for patent prosecution and for patent strategy and management. Additionally the following individuals were recognized as Life Sciences Stars for their outstanding patent work in life sciences:

Jeffrey S. Sharp Managing Partner

David A. Gass Partner

Li-Hsien (Lily) Rin-Laures M.D. Partner

Joseph A. Williams Jr. Ph.D. Partner and Chair of Biotechnology

The Firm’s large Biotechnology Group includes lawyers and patent agents with broad experience in a variety of biotechnology disciplines including: DNA RNA vaccine protein and antibody therapeutics and diagnostics; cell-based and viral therapeutics; drug and gene therapy delivery vehicles; plant biotechnology; industrial technology and research platforms; nanotechnology and interdisciplinary inventions. The Firm’s professionals are skilled at providing patent counseling relating to the interface between patents clinical product development FDA regulations and regulatory exclusivity. The Firm is experienced in traditional chemical-based pharmaceuticals formulations and delivery technologies. The Firm has procured enforced and/or defended patents for biotech companies relating to a number of billion-dollar biologic or pharmaceutical products and handled key patents for clients covering more than a dozen different commercially marketed products and numerous clinical trial candidates.

About Marshall Gerstein & Borun LLP

Marshall Gerstein & Borun LLP is exclusively focused on intellectual property law and works with clients to protect enforce and transfer their intellectual property assets throughout the world. Nearly half of the Firm’s professionals have been in-house as general counsel patent counsel technology transfer managers scientists engineers or consultants. The Firm’s attorneys have the talent and experience to develop and execute intellectual property strategies and comprehensive IP solutions. The Firm represents Fortune 250 corporations multinational businesses start-up organizations and non-profits.